Dr. Hans Vink, Director of Advanced Glycocalyx Research at the Glycocalyx Research Institute, has been instrumental in developing and refining GlycoCheck™, a patented, non-invasive, FDA Class 1 medical device that evaluates the health of the glycocalyx.​Additionally, he and his team have innovated a nutraceutical, proven effective in numerous global clinical studies, for repairing and restoring the function of the glycocalyx, thus significantly aiding in the rejuvenation of health previously compromised by glycocalyx impairment. This nutraceutical's latest iteration is known as ReVasca™.